data_1qm9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qm9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.17 -147.38 4.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.76 135.35 35.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.183 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.586 ' CB ' ' N ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -164.17 63.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.692 ' CG1' ' O ' ' A' ' 46' ' ' VAL . 3.5 t -120.64 132.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.652 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 1.9 mp -86.89 117.74 25.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.684 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' CD2' HD23 ' A' ' 45' ' ' LEU . 2.4 mp -87.75 131.79 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 2.9 t -101.82 130.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 5.7 m -98.36 119.95 37.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.678 ' O ' ' C ' ' A' ' 11' ' ' LEU . 5.6 t-20 -179.96 -82.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.867 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.678 ' C ' ' O ' ' A' ' 10' ' ' ASN . 1.0 OUTLIER -1.74 75.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.864 -0.523 . . . . 0.0 111.023 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.622 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 2.0 m120 -96.26 -65.78 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.847 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' CD ' ' CB ' ' A' ' 12' ' ' ASN . 45.5 Cg_endo -71.86 -166.41 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.666 1.351 . . . . 0.0 110.564 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -98.02 -36.76 10.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.878 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -67.36 -12.97 61.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.495 -0.753 . . . . 0.0 109.469 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.57 ' CG2' ' HG2' ' A' ' 13' ' ' PRO . 37.1 t -96.2 80.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.562 ' CG2' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -92.79 172.7 5.81 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.79 . . . . 0.0 110.181 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.591 ' HD3' HD11 ' A' ' 36' ' ' ILE . 38.1 Cg_endo -63.41 -24.75 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.059 1.558 . . . . 0.0 110.391 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -54.87 -45.15 74.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.494 ' O ' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -74.7 -49.53 20.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.508 HD11 HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -60.54 -41.18 93.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 18' ' ' PRO . 1.3 t80 -57.66 -37.03 72.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.513 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG21 ' N ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -58.22 -37.87 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.819 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.498 ' N ' HG21 ' A' ' 23' ' ' ILE . 1.6 mm? -58.04 -50.85 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' CD1' ' CD1' ' A' ' 61' ' ' LEU . 15.0 m-85 -77.3 -29.05 53.5 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -56.26 -16.66 15.27 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 4.1 p -38.01 -31.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -108.4 -3.74 17.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 44.33 57.03 5.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 1.3 m-20 -126.15 -9.83 6.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.711 ' HA ' ' CB ' ' A' ' 48' ' ' MET . 0.7 OUTLIER -66.79 109.83 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.805 -1.184 . . . . 0.0 109.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 47' ' ' GLN . 52.1 mm-40 -58.95 -36.97 75.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.304 -0.873 . . . . 0.0 110.663 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 2.5 mtm180 -158.75 147.19 18.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.009 . . . . 0.0 111.231 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 34' ' ' VAL . 8.0 p -121.07 133.3 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.501 -0.749 . . . . 0.0 109.779 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -119.11 130.79 55.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.959 . . . . 0.0 110.627 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.591 HD11 ' HD3' ' A' ' 18' ' ' PRO . 1.7 tt -131.12 116.24 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -175.88 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' A' ' 37' ' ' LEU . 41.8 t80 -58.81 -11.86 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.404 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.542 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 4.4 m120 -53.77 -17.71 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.994 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 41' ' ' LYS . 19.0 tttm 47.89 51.78 13.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.244 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' LYS . 6.6 mtmt 57.05 157.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.306 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 10' ' ' ASN . 1.4 mt-10 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.542 ' CB ' ' HB3' ' A' ' 39' ' ' ASN . 8.0 m120 -148.91 154.81 39.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' CB ' HD22 ' A' ' 11' ' ' LEU . . . -157.05 163.62 38.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' CD1' HG13 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -119.9 118.41 30.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.043 -1.036 . . . . 0.0 110.661 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.692 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -115.44 116.52 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.095 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.685 ' HA ' ' CG2' ' A' ' 5' ' ' VAL . 47.2 tt0 -106.34 115.28 29.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 111.888 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.711 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -167.44 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.939 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . . . -53.53 -43.77 68.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 111.876 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.56 ' CA ' ' HB3' ' A' ' 4' ' ' SER . 2.2 m-20 39.89 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 49' ' ' ALA . . . 104.75 -56.2 0.55 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' ALA . 10.9 m120 -74.75 -51.85 13.07 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.939 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.8 mt-30 -58.7 -35.61 72.9 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.507 -1.37 . . . . 0.0 110.728 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.722 ' O ' ' CB ' ' A' ' 58' ' ' MET . . . -57.57 -32.35 67.04 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.986 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 54' ' ' ALA . 4.3 tp60 -54.35 -50.56 67.17 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 117.457 -1.697 . . . . 0.0 106.643 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -75.26 -52.34 11.12 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.798 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' LEU . . . -72.74 -50.47 24.38 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.373 -0.829 . . . . 0.0 112.154 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.722 ' CB ' ' O ' ' A' ' 54' ' ' ALA . 4.8 ttp -54.64 -48.32 72.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.444 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.3 m -75.0 -47.49 28.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 111.425 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 56.0 t-80 -61.71 -40.8 96.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.439 -0.788 . . . . 0.0 111.54 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.672 ' CD1' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.44 -46.16 13.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.998 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 58' ' ' MET . 3.0 m-20 -61.42 176.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 109.814 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.67 24.16 2.67 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.578 ' CE1' ' HG ' ' A' ' 66' ' ' LEU . 4.3 p80 -68.99 -23.36 64.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -1.077 . . . . 0.0 110.625 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 30.8 tttm 70.32 94.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.98 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.578 ' HG ' ' CE1' ' A' ' 64' ' ' HIS . 16.9 mt -78.56 137.75 38.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.444 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 67' ' ' HIS . 7.3 p80 -132.78 6.71 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.854 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.02 -37.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HG3' HG22 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -131.0 118.3 17.47 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.126 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' HD11 ' A' ' 66' ' ' LEU . 47.5 Cg_endo -73.84 96.74 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.005 1.529 . . . . 0.0 110.578 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 71' ' ' ILE . 0.8 OUTLIER -109.67 142.99 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.205 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.89 140.82 41.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 110.331 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 74' ' ' THR . 0.1 OUTLIER -126.78 128.41 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 109.869 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -123.11 163.24 20.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.081 -1.012 . . . . 0.0 110.435 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 76' ' ' SER . 22.7 tp -119.28 118.73 32.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.132 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 75' ' ' LEU . 1.5 p -41.41 138.98 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.273 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -101.65 -90.63 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.56 ' NE2' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 53.64 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -83.37 -32.71 26.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.18 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' GLN . 4.2 t-20 -52.96 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.469 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.2 p -112.5 103.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' NE2' ' NE2' ' A' ' 78' ' ' HIS . 2.1 tp-100 -103.07 141.3 36.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.0 mt -96.95 157.62 34.74 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 45.7 Cg_endo -72.76 -160.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.071 1.564 . . . . 0.0 110.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 20.5 ttp180 56.99 42.21 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.216 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -159.97 38.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.73 60.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 2.1 pt20 -134.53 2.33 3.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -1.146 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER 168.41 10.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.747 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -102.52 0.92 34.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.52 -30.12 15.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 110.182 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.92 -72.75 0.32 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.44 119.24 33.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -1.108 . . . . 0.0 109.917 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 89' ' ' GLU . 16.3 p -133.27 120.82 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' O ' HG11 ' A' ' 34' ' ' VAL . 2.6 mptt -111.91 141.0 46.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 97' ' ' TYR . 3.0 m-20 -102.11 137.01 40.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.5 p90 -25.32 135.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 99' ' ' ASN . . . 87.41 -104.17 2.96 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 25.1 p30 178.24 158.86 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.4 141.71 24.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.66 170.74 18.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.985 1.518 . . . . 0.0 110.414 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.626 HD11 ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -74.48 4.41 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.652 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.626 ' N ' HD11 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -115.46 15.57 16.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 110.281 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -79.43 -48.14 14.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 106' ' ' LYS . 50.3 t80 -110.51 166.51 10.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 mmtp -73.72 -151.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -51.28 107.17 0.76 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 106' ' ' LYS . 46.9 Cg_endo -73.41 -176.66 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.056 1.556 . . . . 0.0 110.475 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.05 135.18 8.81 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.93 -179.88 4.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.04 163.1 13.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -105.41 -139.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.15 101.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.579 ' CG ' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -170.11 60.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.238 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 114' ' ' GLN . 3.0 m120 75.44 107.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 110.048 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -94.53 131.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.735 0.778 . . . . 0.0 110.165 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.8 158.38 39.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.123 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.411 ' HG2' ' CG2' ' A' ' 198' ' ' ILE . 45.0 Cg_endo -72.08 142.66 38.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.003 1.528 . . . . 0.0 110.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.67 97.07 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.096 1.577 . . . . 0.0 110.506 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.97 171.61 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 168' ' ' VAL . . . -134.58 120.17 19.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 111.252 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.526 ' CG2' HD23 ' A' ' 162' ' ' LEU . 0.0 OUTLIER -119.95 117.32 27.76 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.655 HD23 ' CZ ' ' A' ' 141' ' ' PHE . 0.9 OUTLIER -116.34 148.94 40.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.938 -1.102 . . . . 0.0 110.607 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.787 ' CE1' ' HB3' ' A' ' 160' ' ' MET . 1.5 t-80 -115.97 138.99 50.69 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 110.109 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' CD2' HG21 ' A' ' 191' ' ' VAL . 0.2 OUTLIER -99.44 130.48 45.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.563 ' O ' ' C ' ' A' ' 127' ' ' ASN . 3.4 t -87.7 156.03 19.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 110.375 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.59 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 0.1 OUTLIER -15.71 131.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.596 0.712 . . . . 0.0 111.917 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.612 ' CG2' ' HD2' ' A' ' 129' ' ' PRO . 5.1 mp -100.22 149.33 35.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.612 ' HD2' ' CG2' ' A' ' 128' ' ' ILE . 43.1 Cg_endo -68.79 154.06 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.791 1.416 . . . . 0.0 110.584 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.1 78.81 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.031 1.543 . . . . 0.0 110.438 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 t 177.66 -38.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.931 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.4 t -101.82 125.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 109.951 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.86 173.36 11.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.234 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 153' ' ' PHE . 17.9 mt-10 -66.61 -29.34 69.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -61.28 -36.44 80.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 1.8 m-20 -62.84 -47.58 82.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.424 HD23 ' CG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -71.78 -45.48 61.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.899 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.557 ' HE3' ' CE1' ' A' ' 151' ' ' PHE . 13.0 tttm -55.02 -40.69 70.43 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.528 -0.732 . . . . 0.0 109.959 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 135' ' ' GLU . 12.8 t -67.35 -39.27 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' CB ' ' CD1' ' A' ' 178' ' ' LEU . 83.8 mt -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.535 -0.728 . . . . 0.0 110.014 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.655 ' CZ ' HD23 ' A' ' 123' ' ' LEU . 7.1 m-85 -54.21 -29.43 46.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.869 . . . . 0.0 110.268 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.413 ' HA ' ' CG2' ' A' ' 148' ' ' VAL . 0.9 OUTLIER -81.98 -65.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -74.53 -36.99 63.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 111.074 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.529 ' HB2' ' CD2' ' A' ' 178' ' ' LEU . 3.8 m-80 -97.16 -30.35 13.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.224 -0.923 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LEU . . . -70.7 -58.18 6.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.538 ' HA2' ' CG ' ' A' ' 170' ' ' GLU . . . 140.49 -82.17 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.59 107.51 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 110.229 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 142' ' ' SER . 75.8 t -100.75 108.59 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.0 -15.63 53.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.05 153.11 6.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 163' ' ' ILE . 4.3 p90 -136.15 134.33 38.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -1.139 . . . . 0.0 110.237 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HB3' ' CE2' ' A' ' 154' ' ' PHE . 1.5 mtpt -119.21 115.06 23.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 110.021 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 2.6 m-85 -99.63 129.81 45.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.004 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 0.1 OUTLIER -167.85 -164.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.611 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.631 ' O ' ' C ' ' A' ' 156' ' ' LYS . 16.3 pt20 -79.66 -7.9 58.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.637 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.636 ' HB2' ' CE1' ' A' ' 154' ' ' PHE . 12.6 tptt -17.65 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.634 -0.666 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.505 ' C ' ' HB2' ' A' ' 160' ' ' MET . 0.2 OUTLIER -76.57 46.26 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.893 -1.129 . . . . 0.0 110.974 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 155' ' ' GLN . 7.7 ttp180 62.92 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 110.386 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.494 ' HB3' ' HE2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER 52.12 22.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' MET . . . . . 0.787 ' HB3' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -112.39 169.63 8.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.677 -0.639 . . . . 0.0 109.618 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.71 ' N ' ' CE1' ' A' ' 124' ' ' HIS . . . -146.35 162.13 38.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.873 -1.142 . . . . 0.0 109.637 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 124' ' ' HIS . 1.9 tt -126.12 147.57 49.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.042 -1.036 . . . . 0.0 110.607 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -128.75 139.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.926 . . . . 0.0 110.162 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.48 ' C ' ' HG3' ' A' ' 165' ' ' MET . 0.1 OUTLIER -95.95 134.17 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.554 ' O ' ' C ' ' A' ' 166' ' ' GLY . 0.0 OUTLIER -140.22 92.46 2.54 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 109.126 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 165' ' ' MET . . . -28.5 -74.72 0.03 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 74.6 m -58.51 108.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 11.7 t -61.26 -44.91 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 110.43 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.52 -32.32 49.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.434 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.538 ' CG ' ' HA2' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -69.5 -38.81 77.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.586 -0.696 . . . . 0.0 110.181 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -57.41 -46.13 83.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.009 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.78 -36.63 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.606 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 177' ' ' ASP . 4.9 tt0 -53.74 -34.19 58.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.455 -0.778 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.649 ' HB2' ' CD1' ' A' ' 141' ' ' PHE . . . -58.33 -42.85 87.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.012 -1.055 . . . . 0.0 110.499 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 191' ' ' VAL . 3.0 tp -57.54 -50.39 73.26 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 109.14 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 180' ' ' ASN . 25.2 mm -70.07 -47.64 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.612 0.72 . . . . 0.0 110.719 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.42 ' HB3' ' HB3' ' A' ' 144' ' ' ASN . 1.5 m-20 -71.79 -49.0 42.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.454 -0.779 . . . . 0.0 112.028 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.692 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -61.06 -43.95 98.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.018 -1.051 . . . . 0.0 109.213 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 189' ' ' LEU . 15.0 m170 -112.85 37.78 3.0 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.743 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.546 ' CA ' ' O ' ' A' ' 176' ' ' ILE . 11.3 t-20 -58.98 -39.19 80.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.256 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -117.82 106.52 13.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -113.98 -162.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.187 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.6 OUTLIER -126.4 -28.34 3.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.463 ' N ' ' HG ' ' A' ' 183' ' ' LEU . . . 159.97 -78.48 0.17 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 186' ' ' ASN . 1.2 tt0 -51.88 -25.86 8.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 0.0 110.114 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.5 ' C ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER 65.94 10.98 7.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.344 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 129' ' ' PRO . 5.9 m80 68.27 -173.84 0.19 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.59 ' CE1' ' HB2' ' A' ' 127' ' ' ASN . 56.0 t-80 -101.85 -1.66 31.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 110.15 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 179' ' ' HIS . 3.2 pp -76.02 119.98 20.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.918 . . . . 0.0 109.339 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.505 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 0.0 OUTLIER -113.5 137.15 51.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.087 -1.008 . . . . 0.0 111.272 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 123' ' ' LEU . 9.8 t -117.74 117.69 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 109.654 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.547 ' N ' HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -128.93 140.92 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 193' ' ' PHE . 5.3 p90 -87.91 123.43 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 146.06 47.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -104.77 110.39 22.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 110.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 -143.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.887 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -74.49 158.64 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 109.943 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.569 ' CD1' ' O ' ' A' ' 197' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.17 -147.38 4.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.76 135.35 35.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.183 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.856 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -164.17 63.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.221 HG13 ' O ' ' A' ' 46' ' ' VAL . 3.5 t -120.64 132.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.652 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 58' ' ' MET . 1.9 mp -86.89 117.74 25.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.684 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' HG ' HD13 ' A' ' 45' ' ' LEU . 2.4 mp -87.75 131.79 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 2.9 t -101.82 130.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 5.7 m -98.36 119.95 37.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.678 ' O ' ' C ' ' A' ' 11' ' ' LEU . 5.6 t-20 -179.96 -82.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.867 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -1.74 75.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.864 -0.523 . . . . 0.0 111.023 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.622 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 2.0 m120 -96.26 -65.78 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.847 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' CD ' ' CB ' ' A' ' 12' ' ' ASN . 45.5 Cg_endo -71.86 -166.41 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.666 1.351 . . . . 0.0 110.564 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -98.02 -36.76 10.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.878 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -67.36 -12.97 61.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.495 -0.753 . . . . 0.0 109.469 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 16' ' ' VAL . 37.1 t -96.2 80.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -92.79 172.7 5.81 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.79 . . . . 0.0 110.181 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 17' ' ' THR . 38.1 Cg_endo -63.41 -24.75 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.059 1.558 . . . . 0.0 110.391 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -54.87 -45.15 74.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -74.7 -49.53 20.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.637 HD11 ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -60.54 -41.18 93.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PRO . 1.3 t80 -57.66 -37.03 72.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.513 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -58.22 -37.87 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.819 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.6 mm? -58.04 -50.85 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.149 ' CZ ' HD22 ' A' ' 61' ' ' LEU . 15.0 m-85 -77.3 -29.05 53.5 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -56.26 -16.66 15.27 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 4.1 p -38.01 -31.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -108.4 -3.74 17.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 44.33 57.03 5.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 1.3 m-20 -126.15 -9.83 6.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -66.79 109.83 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.805 -1.184 . . . . 0.0 109.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 47' ' ' GLN . 52.1 mm-40 -58.95 -36.97 75.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.304 -0.873 . . . . 0.0 110.663 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 2.5 mtm180 -158.75 147.19 18.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.009 . . . . 0.0 111.231 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 34' ' ' VAL . 8.0 p -121.07 133.3 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.501 -0.749 . . . . 0.0 109.779 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -119.11 130.79 55.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.959 . . . . 0.0 110.627 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.855 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.7 tt -131.12 116.24 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.855 HD23 ' C ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -175.88 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -58.81 -11.86 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.404 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 4.4 m120 -53.77 -17.71 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.994 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 41' ' ' LYS . 19.0 tttm 47.89 51.78 13.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.244 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' LYS . 6.6 mtmt 57.05 157.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.306 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.4 mt-10 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 39' ' ' ASN . 8.0 m120 -148.91 154.81 39.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . . . -157.05 163.62 38.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD12 HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -119.9 118.41 30.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.043 -1.036 . . . . 0.0 110.661 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.221 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -115.44 116.52 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.095 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 1.112 ' HA ' HG22 ' A' ' 5' ' ' VAL . 47.2 tt0 -106.34 115.28 29.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 111.888 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -167.44 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . . . -53.53 -43.77 68.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 111.876 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.578 ' CA ' ' HB3' ' A' ' 4' ' ' SER . 2.2 m-20 39.89 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 49' ' ' ALA . . . 104.75 -56.2 0.55 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' ALA . 10.9 m120 -74.75 -51.85 13.07 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.991 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.8 mt-30 -58.7 -35.61 72.9 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.507 -1.37 . . . . 0.0 110.728 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.78 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -57.57 -32.35 67.04 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.986 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 54' ' ' ALA . 4.3 tp60 -54.35 -50.56 67.17 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 117.457 -1.697 . . . . 0.0 106.643 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -75.26 -52.34 11.12 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.798 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 61' ' ' LEU . . . -72.74 -50.47 24.38 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.373 -0.829 . . . . 0.0 112.154 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.78 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 4.8 ttp -54.64 -48.32 72.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.444 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.3 m -75.0 -47.49 28.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 111.425 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 56.0 t-80 -61.71 -40.8 96.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.439 -0.788 . . . . 0.0 111.54 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.149 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.44 -46.16 13.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.998 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 58' ' ' MET . 3.0 m-20 -61.42 176.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 109.814 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.67 24.16 2.67 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 65' ' ' LYS . 1.7 p-80 -68.99 -23.36 64.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -1.077 . . . . 0.0 110.625 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 64' ' ' HIS . 30.8 tttm 70.32 94.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.98 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 71' ' ' ILE . 16.9 mt -78.56 137.75 38.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.444 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -132.78 6.71 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.854 . . . . 0.0 110.154 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.02 -37.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.631 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.0 118.3 17.47 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.126 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HA ' HD13 ' A' ' 66' ' ' LEU . 47.5 Cg_endo -73.84 96.74 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.005 1.529 . . . . 0.0 110.578 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.765 HG12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -109.67 142.99 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.205 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -108.89 140.82 41.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 110.331 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.552 HD11 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -126.78 128.41 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 109.869 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.517 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -123.11 163.24 20.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.081 -1.012 . . . . 0.0 110.435 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 76' ' ' SER . 22.7 tp -119.28 118.73 32.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.132 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 75' ' ' LEU . 1.5 p -41.41 138.98 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.273 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -101.65 -90.63 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.407 ' NE2' ' OE1' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 53.64 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -83.37 -32.71 26.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.18 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' GLN . 4.2 t-20 -52.96 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.2 p -112.5 103.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' OE1' ' NE2' ' A' ' 78' ' ' HIS . 15.2 tp60 -103.07 141.3 36.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.0 mt -96.95 157.62 34.74 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 45.7 Cg_endo -72.76 -160.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.071 1.564 . . . . 0.0 110.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 20.5 ttp180 56.99 42.21 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.216 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -159.97 38.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.73 60.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 2.1 pt20 -134.53 2.33 3.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -1.146 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.67 ' HA ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER 168.41 10.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.747 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -102.52 0.92 34.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.52 -30.12 15.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 110.182 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.92 -72.75 0.32 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.44 119.24 33.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -1.108 . . . . 0.0 109.917 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 89' ' ' GLU . 16.3 p -133.27 120.82 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -111.91 141.0 46.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 97' ' ' TYR . 3.0 m-20 -102.11 137.01 40.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.5 p90 -25.32 135.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASN . . . 87.41 -104.17 2.96 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 25.1 p30 178.24 158.86 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.4 141.71 24.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.66 170.74 18.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.985 1.518 . . . . 0.0 110.414 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.97 HD22 ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.48 4.41 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.652 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.665 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -115.46 15.57 16.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 110.281 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -79.43 -48.14 14.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 106' ' ' LYS . 50.3 t80 -110.51 166.51 10.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 105' ' ' PHE . 5.5 mmtp -73.72 -151.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -51.28 107.17 0.76 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 106' ' ' LYS . 46.9 Cg_endo -73.41 -176.66 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.056 1.556 . . . . 0.0 110.475 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.05 135.18 8.81 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.93 -179.88 4.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.04 163.1 13.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -105.41 -139.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.15 101.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.579 ' O ' ' CG ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -170.11 60.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.238 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 114' ' ' GLN . 3.0 m120 75.44 107.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 110.048 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -94.53 131.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.735 0.778 . . . . 0.0 110.165 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.8 158.38 39.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.123 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.916 ' HG2' HG22 ' A' ' 198' ' ' ILE . 45.0 Cg_endo -72.08 142.66 38.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.003 1.528 . . . . 0.0 110.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.67 97.07 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.096 1.577 . . . . 0.0 110.506 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.58 ' O ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.97 171.61 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.036 ' HB2' ' HA ' ' A' ' 168' ' ' VAL . . . -134.58 120.17 19.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 111.252 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.544 HG23 ' HG3' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -119.95 117.32 27.76 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.905 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -116.34 148.94 40.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.938 -1.102 . . . . 0.0 110.607 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.782 ' CD2' ' HB3' ' A' ' 160' ' ' MET . 1.4 t60 -115.97 138.99 50.69 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 110.109 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.81 ' HG ' HD22 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -99.44 130.48 45.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.563 ' O ' ' C ' ' A' ' 127' ' ' ASN . 3.4 t -87.7 156.03 19.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 110.375 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.616 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 0.1 OUTLIER -15.71 131.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.596 0.712 . . . . 0.0 111.917 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 129' ' ' PRO . 5.1 mp -100.22 149.33 35.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.728 ' HD2' HG23 ' A' ' 128' ' ' ILE . 43.1 Cg_endo -68.79 154.06 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.791 1.416 . . . . 0.0 110.584 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.1 78.81 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.031 1.543 . . . . 0.0 110.438 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 t 177.66 -38.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.931 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.4 t -101.82 125.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 109.951 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.86 173.36 11.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.234 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.61 -29.34 69.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.28 -36.44 80.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 1.8 m-20 -62.84 -47.58 82.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.81 HD22 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -71.78 -45.48 61.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.899 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 151' ' ' PHE . 13.0 tttm -55.02 -40.69 70.43 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.528 -0.732 . . . . 0.0 109.959 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 t -67.35 -39.27 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.109 ' CB ' HD13 ' A' ' 178' ' ' LEU . 83.8 mt -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.535 -0.728 . . . . 0.0 110.014 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.655 ' CE1' ' HB1' ' A' ' 174' ' ' ALA . 7.1 m-85 -54.21 -29.43 46.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.869 . . . . 0.0 110.268 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.448 ' HA ' HG23 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -81.98 -65.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -74.53 -36.99 63.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 111.074 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 178' ' ' LEU . 8.4 m120 -97.16 -30.35 13.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.224 -0.923 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LEU . . . -70.7 -58.18 6.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.545 ' HA3' ' CG ' ' A' ' 170' ' ' GLU . . . 140.49 -82.17 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 170' ' ' GLU . 99.6 t -123.59 107.51 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 110.229 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 142' ' ' SER . 75.8 t -100.75 108.59 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.0 -15.63 53.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.05 153.11 6.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 1.057 ' CB ' HG23 ' A' ' 163' ' ' ILE . 4.3 p90 -136.15 134.33 38.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -1.139 . . . . 0.0 110.237 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 154' ' ' PHE . 1.5 mtpt -119.21 115.06 23.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 110.021 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.644 ' HA ' ' HB1' ' A' ' 161' ' ' ALA . 2.6 m-85 -99.63 129.81 45.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.004 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -167.85 -164.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.611 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.631 ' O ' ' C ' ' A' ' 156' ' ' LYS . 16.3 pt20 -79.66 -7.9 58.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.637 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.773 ' HG2' ' HE1' ' A' ' 124' ' ' HIS . 12.6 tptt -17.65 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.634 -0.666 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.52 ' C ' ' HB2' ' A' ' 160' ' ' MET . 0.2 OUTLIER -76.57 46.26 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.893 -1.129 . . . . 0.0 110.974 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 155' ' ' GLN . 7.7 ttp180 62.92 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 110.386 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER 52.12 22.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' MET . . . . . 0.782 ' HB3' ' CD2' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -112.39 169.63 8.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.677 -0.639 . . . . 0.0 109.618 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 124' ' ' HIS . . . -146.35 162.13 38.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.873 -1.142 . . . . 0.0 109.637 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 163' ' ' ILE . 1.9 tt -126.12 147.57 49.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.042 -1.036 . . . . 0.0 110.607 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.057 HG23 ' CB ' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -128.75 139.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.926 . . . . 0.0 110.162 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.544 ' HG3' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -95.95 134.17 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.743 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -140.22 92.46 2.54 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 109.126 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 165' ' ' MET . . . -28.5 -74.72 0.03 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 74.6 m -58.51 108.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.036 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 11.7 t -61.26 -44.91 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 110.43 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.52 -32.32 49.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.434 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.545 ' CG ' ' HA3' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -69.5 -38.81 77.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.586 -0.696 . . . . 0.0 110.181 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . . . -57.41 -46.13 83.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.009 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.78 -36.63 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.606 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 177' ' ' ASP . 4.9 tt0 -53.74 -34.19 58.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.455 -0.778 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.655 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -58.33 -42.85 87.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.012 -1.055 . . . . 0.0 110.499 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.891 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.0 tp -57.54 -50.39 73.26 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 109.14 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 180' ' ' ASN . 25.2 mm -70.07 -47.64 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.612 0.72 . . . . 0.0 110.719 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 144' ' ' ASN . 1.5 m-20 -71.79 -49.0 42.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.454 -0.779 . . . . 0.0 112.028 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.109 HD13 ' CB ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -61.06 -43.95 98.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.018 -1.051 . . . . 0.0 109.213 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.449 ' NE2' ' CD1' ' A' ' 189' ' ' LEU . 11.7 m-70 -112.85 37.78 3.0 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.743 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.546 ' CA ' ' O ' ' A' ' 176' ' ' ILE . 11.3 t-20 -58.98 -39.19 80.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.256 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -117.82 106.52 13.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -113.98 -162.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.187 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 183' ' ' LEU . 0.6 OUTLIER -126.4 -28.34 3.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 183' ' ' LEU . . . 159.97 -78.48 0.17 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 186' ' ' ASN . 1.2 tt0 -51.88 -25.86 8.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 0.0 110.114 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.5 ' C ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER 65.94 10.98 7.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.344 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.685 ' NE2' HD21 ' A' ' 183' ' ' LEU . 5.9 m80 68.27 -173.84 0.19 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 127' ' ' ASN . 56.0 t-80 -101.85 -1.66 31.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 110.15 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.2 pp -76.02 119.98 20.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.918 . . . . 0.0 109.339 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.642 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -113.5 137.15 51.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.087 -1.008 . . . . 0.0 111.272 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.891 ' HB ' HD12 ' A' ' 175' ' ' LEU . 9.8 t -117.74 117.69 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 109.654 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.575 ' C ' HD12 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -128.93 140.92 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 193' ' ' PHE . 5.3 p90 -87.91 123.43 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 146.06 47.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -104.77 110.39 22.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 110.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 -143.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.887 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -74.49 158.64 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 109.943 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 118' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.27 0.557 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.17 -147.38 4.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.76 135.35 35.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -1.149 . . . . 0.0 110.183 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.856 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -164.17 63.75 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.271 -0.893 . . . . 0.0 110.256 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.221 HG13 ' O ' ' A' ' 46' ' ' VAL . 3.5 t -120.64 132.31 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.652 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 58' ' ' MET . 1.9 mp -86.89 117.74 25.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 110.684 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' HG ' HD13 ' A' ' 45' ' ' LEU . 2.4 mp -87.75 131.79 34.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 2.9 t -101.82 130.78 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 5.7 m -98.36 119.95 37.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.303 -0.873 . . . . 0.0 110.247 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.678 ' O ' ' C ' ' A' ' 11' ' ' LEU . 5.6 t-20 -179.96 -82.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.867 . . . . 0.0 109.874 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -1.74 75.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.864 -0.523 . . . . 0.0 111.023 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.622 ' CB ' ' CD ' ' A' ' 13' ' ' PRO . 2.0 m120 -96.26 -65.78 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.847 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.622 ' CD ' ' CB ' ' A' ' 12' ' ' ASN . 45.5 Cg_endo -71.86 -166.41 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.666 1.351 . . . . 0.0 110.564 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -98.02 -36.76 10.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.878 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -67.36 -12.97 61.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.495 -0.753 . . . . 0.0 109.469 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 16' ' ' VAL . 37.1 t -96.2 80.88 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.972 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -92.79 172.7 5.81 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.437 -0.79 . . . . 0.0 110.181 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 17' ' ' THR . 38.1 Cg_endo -63.41 -24.75 71.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.059 1.558 . . . . 0.0 110.391 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -54.87 -45.15 74.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -74.7 -49.53 20.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.637 HD11 ' CG1' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -60.54 -41.18 93.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PRO . 1.3 t80 -57.66 -37.03 72.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.513 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -58.22 -37.87 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.851 . . . . 0.0 109.819 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 1.6 mm? -58.04 -50.85 72.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.149 ' CZ ' HD22 ' A' ' 61' ' ' LEU . 15.0 m-85 -77.3 -29.05 53.5 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 29' ' ' GLY . . . -56.26 -16.66 15.27 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 26' ' ' GLY . 4.1 p -38.01 -31.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -108.4 -3.74 17.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 0.0 110.619 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 44.33 57.03 5.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 28' ' ' TYR . 1.3 m-20 -126.15 -9.83 6.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.245 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.698 ' HA ' ' O ' ' A' ' 47' ' ' GLN . 0.7 OUTLIER -66.79 109.83 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.805 -1.184 . . . . 0.0 109.31 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' A' ' 47' ' ' GLN . 52.1 mm-40 -58.95 -36.97 75.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.304 -0.873 . . . . 0.0 110.663 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 2.5 mtm180 -158.75 147.19 18.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.009 . . . . 0.0 111.231 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 34' ' ' VAL . 8.0 p -121.07 133.3 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.501 -0.749 . . . . 0.0 109.779 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -119.11 130.79 55.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.959 . . . . 0.0 110.627 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.855 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.7 tt -131.12 116.24 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 110.1 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.855 HD23 ' C ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -175.88 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 110.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -58.81 -11.86 3.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.141 -0.975 . . . . 0.0 110.404 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HB3' ' CB ' ' A' ' 43' ' ' ASN . 4.4 m120 -53.77 -17.71 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.994 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 41' ' ' LYS . 19.0 tttm 47.89 51.78 13.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.244 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 40' ' ' LYS . 6.6 mtmt 57.05 157.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 110.306 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' SER . 1.4 mt-10 65.65 10.91 7.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.516 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 39' ' ' ASN . 8.0 m120 -148.91 154.81 39.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.577 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . . . -157.05 163.62 38.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.404 -0.81 . . . . 0.0 109.612 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD12 HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -119.9 118.41 30.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.043 -1.036 . . . . 0.0 110.661 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.221 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -115.44 116.52 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.095 179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 1.112 ' HA ' HG22 ' A' ' 5' ' ' VAL . 47.2 tt0 -106.34 115.28 29.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 111.888 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 49' ' ' ALA . 0.0 OUTLIER -167.44 -39.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.536 0.684 . . . . 0.0 109.889 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . . . -53.53 -43.77 68.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.545 -0.722 . . . . 0.0 111.876 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.578 ' CA ' ' HB3' ' A' ' 4' ' ' SER . 2.2 m-20 39.89 19.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 49' ' ' ALA . . . 104.75 -56.2 0.55 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' ALA . 10.9 m120 -74.75 -51.85 13.07 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.991 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . 8.8 mt-30 -58.7 -35.61 72.9 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.507 -1.37 . . . . 0.0 110.728 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.78 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -57.57 -32.35 67.04 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.986 177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 54' ' ' ALA . 4.3 tp60 -54.35 -50.56 67.17 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 117.457 -1.697 . . . . 0.0 106.643 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' O ' ' CB ' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -75.26 -52.34 11.12 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.798 177.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 61' ' ' LEU . . . -72.74 -50.47 24.38 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.373 -0.829 . . . . 0.0 112.154 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.78 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 4.8 ttp -54.64 -48.32 72.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.444 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.3 m -75.0 -47.49 28.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 111.425 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' LEU . 56.0 t-80 -61.71 -40.8 96.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.439 -0.788 . . . . 0.0 111.54 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.149 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.44 -46.16 13.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 110.998 -179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' CG ' ' O ' ' A' ' 58' ' ' MET . 3.0 m-20 -61.42 176.19 0.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.157 -0.965 . . . . 0.0 109.814 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.67 24.16 2.67 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.587 ' CE1' ' HG ' ' A' ' 66' ' ' LEU . 4.3 p80 -68.99 -23.36 64.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -1.077 . . . . 0.0 110.625 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 64' ' ' HIS . 30.8 tttm 70.32 94.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.98 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 71' ' ' ILE . 16.9 mt -78.56 137.75 38.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.444 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 67' ' ' HIS . 7.3 p80 -132.78 6.71 4.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.854 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -149.02 -37.53 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.631 ' O ' HD22 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -131.0 118.3 17.47 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.287 -1.126 . . . . 0.0 110.267 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HA ' HD13 ' A' ' 66' ' ' LEU . 47.5 Cg_endo -73.84 96.74 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.005 1.529 . . . . 0.0 110.578 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.765 HG12 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -109.67 142.99 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.299 -0.876 . . . . 0.0 110.205 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.415 ' HB3' ' CB ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -108.89 140.82 41.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 110.331 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.552 HD11 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -126.78 128.41 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.91 . . . . 0.0 109.869 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.517 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -123.11 163.24 20.91 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.081 -1.012 . . . . 0.0 110.435 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 76' ' ' SER . 22.7 tp -119.28 118.73 32.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.132 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 75' ' ' LEU . 1.5 p -41.41 138.98 1.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.273 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -101.65 -90.63 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.276 -0.89 . . . . 0.0 110.225 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.56 ' NE2' ' NE2' ' A' ' 82' ' ' GLN . 0.1 OUTLIER 53.64 91.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -83.37 -32.71 26.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 110.18 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' GLN . 4.2 t-20 -52.96 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.913 . . . . 0.0 110.22 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.2 p -112.5 103.07 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.56 ' NE2' ' NE2' ' A' ' 78' ' ' HIS . 2.1 tp-100 -103.07 141.3 36.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.0 mt -96.95 157.62 34.74 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 0.0 110.145 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 85' ' ' ARG . 45.7 Cg_endo -72.76 -160.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.071 1.564 . . . . 0.0 110.451 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 84' ' ' PRO . 20.5 ttp180 56.99 42.21 26.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.216 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -159.97 38.5 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.73 60.21 0.08 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.517 ' O ' ' CB ' ' A' ' 89' ' ' GLU . 2.1 pt20 -134.53 2.33 3.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -1.146 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.67 ' HA ' HG21 ' A' ' 94' ' ' THR . 0.0 OUTLIER 168.41 10.44 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.747 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -102.52 0.92 34.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.52 -30.12 15.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 0.0 110.182 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 145.92 -72.75 0.32 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.633 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.44 119.24 33.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.317 -1.108 . . . . 0.0 109.917 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 89' ' ' GLU . 16.3 p -133.27 120.82 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.844 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -111.91 141.0 46.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.598 ' O ' ' C ' ' A' ' 97' ' ' TYR . 3.0 m-20 -102.11 137.01 40.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 110.119 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.598 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.5 p90 -25.32 135.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.575 -0.703 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASN . . . 87.41 -104.17 2.96 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 98' ' ' GLY . 25.1 p30 178.24 158.86 0.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.278 -1.131 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.4 141.71 24.28 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.169 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.66 170.74 18.76 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.985 1.518 . . . . 0.0 110.414 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.97 HD22 ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -74.48 4.41 6.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.898 . . . . 0.0 110.652 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.665 ' N ' HD13 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -115.46 15.57 16.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.119 -0.988 . . . . 0.0 110.281 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -79.43 -48.14 14.48 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 106' ' ' LYS . 50.3 t80 -110.51 166.51 10.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' N ' ' CG ' ' A' ' 105' ' ' PHE . 5.5 mmtp -73.72 -151.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 110.313 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -51.28 107.17 0.76 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.145 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 106' ' ' LYS . 46.9 Cg_endo -73.41 -176.66 2.59 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.056 1.556 . . . . 0.0 110.475 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.05 135.18 8.81 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.93 -179.88 4.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.04 163.1 13.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -105.41 -139.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 56.15 101.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.155 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.579 ' O ' ' CG ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -170.11 60.49 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.238 -0.914 . . . . 0.0 110.238 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 114' ' ' GLN . 3.0 m120 75.44 107.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 110.048 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.693 HG13 ' O ' ' A' ' 116' ' ' ILE . 0.7 OUTLIER -94.53 131.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-O 121.735 0.778 . . . . 0.0 110.165 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -113.8 158.38 39.19 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.123 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.916 ' HG2' HG22 ' A' ' 198' ' ' ILE . 45.0 Cg_endo -72.08 142.66 38.66 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.003 1.528 . . . . 0.0 110.443 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.67 97.07 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.096 1.577 . . . . 0.0 110.506 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.58 ' O ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.97 171.61 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.021 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.036 ' HB2' ' HA ' ' A' ' 168' ' ' VAL . . . -134.58 120.17 19.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 111.252 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.544 HG23 ' HG3' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -119.95 117.32 27.76 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.905 ' O ' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -116.34 148.94 40.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.938 -1.102 . . . . 0.0 110.607 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.802 ' CE1' ' HB3' ' A' ' 160' ' ' MET . 1.5 t-80 -115.97 138.99 50.69 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 110.109 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.81 ' HG ' HD22 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -99.44 130.48 45.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.913 . . . . 0.0 110.14 -179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.563 ' O ' ' C ' ' A' ' 127' ' ' ASN . 3.4 t -87.7 156.03 19.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -0.87 . . . . 0.0 110.375 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.616 ' HB2' ' CE1' ' A' ' 188' ' ' HIS . 0.1 OUTLIER -15.71 131.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.596 0.712 . . . . 0.0 111.917 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.728 HG23 ' HD2' ' A' ' 129' ' ' PRO . 5.1 mp -100.22 149.33 35.94 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.538 -0.726 . . . . 0.0 109.761 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.728 ' HD2' HG23 ' A' ' 128' ' ' ILE . 43.1 Cg_endo -68.79 154.06 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.791 1.416 . . . . 0.0 110.584 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.1 78.81 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.031 1.543 . . . . 0.0 110.438 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 t 177.66 -38.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.332 -0.855 . . . . 0.0 109.931 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.4 t -101.82 125.18 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 109.951 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.86 173.36 11.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.234 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -66.61 -29.34 69.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.28 -36.44 80.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.272 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.478 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 1.8 m-20 -62.84 -47.58 82.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.846 . . . . 0.0 110.163 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.81 HD22 ' HG ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -71.78 -45.48 61.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.899 . . . . 0.0 110.055 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 151' ' ' PHE . 13.0 tttm -55.02 -40.69 70.43 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.528 -0.732 . . . . 0.0 109.959 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 t -67.35 -39.27 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.109 ' CB ' HD13 ' A' ' 178' ' ' LEU . 83.8 mt -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.535 -0.728 . . . . 0.0 110.014 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.655 ' CE1' ' HB1' ' A' ' 174' ' ' ALA . 7.1 m-85 -54.21 -29.43 46.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.869 . . . . 0.0 110.268 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.448 ' HA ' HG23 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -81.98 -65.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 110.852 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.5 m -74.53 -36.99 63.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 111.074 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 178' ' ' LEU . 3.8 m-80 -97.16 -30.35 13.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.224 -0.923 . . . . 0.0 110.594 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 140' ' ' LEU . . . -70.7 -58.18 6.0 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.545 ' HA3' ' CG ' ' A' ' 170' ' ' GLU . . . 140.49 -82.17 0.24 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 170' ' ' GLU . 99.6 t -123.59 107.51 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -1.153 . . . . 0.0 110.229 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 142' ' ' SER . 75.8 t -100.75 108.59 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 110.132 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.0 -15.63 53.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.145 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 155.05 153.11 6.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 1.057 ' CB ' HG23 ' A' ' 163' ' ' ILE . 4.3 p90 -136.15 134.33 38.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -1.139 . . . . 0.0 110.237 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HB3' ' CE2' ' A' ' 154' ' ' PHE . 1.5 mtpt -119.21 115.06 23.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 110.021 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.644 ' HA ' ' HB1' ' A' ' 161' ' ' ALA . 2.6 m-85 -99.63 129.81 45.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 110.004 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.663 ' CE1' ' HB2' ' A' ' 156' ' ' LYS . 0.1 OUTLIER -167.85 -164.77 0.58 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.611 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.631 ' O ' ' C ' ' A' ' 156' ' ' LYS . 16.3 pt20 -79.66 -7.9 58.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 110.637 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.663 ' HB2' ' CE1' ' A' ' 154' ' ' PHE . 12.6 tptt -17.65 -98.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.634 -0.666 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.52 ' C ' ' HB2' ' A' ' 160' ' ' MET . 0.2 OUTLIER -76.57 46.26 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.893 -1.129 . . . . 0.0 110.974 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.469 ' N ' ' O ' ' A' ' 155' ' ' GLN . 7.7 ttp180 62.92 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.031 . . . . 0.0 110.386 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 159' ' ' LYS . 0.8 OUTLIER 52.12 22.1 1.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.895 . . . . 0.0 109.415 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' MET . . . . . 0.802 ' HB3' ' CE1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -112.39 169.63 8.74 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.677 -0.639 . . . . 0.0 109.618 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.713 ' O ' ' HA ' ' A' ' 124' ' ' HIS . . . -146.35 162.13 38.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.873 -1.142 . . . . 0.0 109.637 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 163' ' ' ILE . 1.9 tt -126.12 147.57 49.58 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.042 -1.036 . . . . 0.0 110.607 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.057 HG23 ' CB ' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -128.75 139.42 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.219 -0.926 . . . . 0.0 110.162 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.544 ' HG3' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -95.95 134.17 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.259 -0.901 . . . . 0.0 110.135 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.743 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -140.22 92.46 2.54 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 109.126 179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 165' ' ' MET . . . -28.5 -74.72 0.03 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 170' ' ' GLU . 74.6 m -58.51 108.41 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.036 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 11.7 t -61.26 -44.91 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 110.43 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -53.52 -32.32 49.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.434 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.545 ' CG ' ' HA3' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -69.5 -38.81 77.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.586 -0.696 . . . . 0.0 110.181 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.644 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . . . -57.41 -46.13 83.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.009 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.78 -36.63 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.606 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 177' ' ' ASP . 4.9 tt0 -53.74 -34.19 58.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.455 -0.778 . . . . 0.0 110.262 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.655 ' HB1' ' CE1' ' A' ' 141' ' ' PHE . . . -58.33 -42.85 87.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.012 -1.055 . . . . 0.0 110.499 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.891 HD12 ' HB ' ' A' ' 191' ' ' VAL . 3.0 tp -57.54 -50.39 73.26 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 109.14 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.546 ' O ' ' CA ' ' A' ' 180' ' ' ASN . 25.2 mm -70.07 -47.64 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.612 0.72 . . . . 0.0 110.719 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 144' ' ' ASN . 1.5 m-20 -71.79 -49.0 42.64 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.454 -0.779 . . . . 0.0 112.028 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.109 HD13 ' CB ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -61.06 -43.95 98.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.018 -1.051 . . . . 0.0 109.213 -179.257 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.649 ' CE1' ' CD1' ' A' ' 189' ' ' LEU . 15.0 m170 -112.85 37.78 3.0 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.743 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.546 ' CA ' ' O ' ' A' ' 176' ' ' ILE . 11.3 t-20 -58.98 -39.19 80.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 110.256 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -117.82 106.52 13.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -113.98 -162.02 0.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.187 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 183' ' ' LEU . 0.6 OUTLIER -126.4 -28.34 3.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.243 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.47 ' N ' ' HG ' ' A' ' 183' ' ' LEU . . . 159.97 -78.48 0.17 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.441 ' O ' ' CB ' ' A' ' 186' ' ' ASN . 1.2 tt0 -51.88 -25.86 8.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 0.0 110.114 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.5 ' C ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER 65.94 10.98 7.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 110.344 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.685 ' NE2' HD21 ' A' ' 183' ' ' LEU . 5.9 m80 68.27 -173.84 0.19 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.244 -0.91 . . . . 0.0 110.351 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 127' ' ' ASN . 56.0 t-80 -101.85 -1.66 31.69 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 110.15 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 189' ' ' LEU . 3.2 pp -76.02 119.98 20.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.918 . . . . 0.0 109.339 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.642 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -113.5 137.15 51.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.087 -1.008 . . . . 0.0 111.272 -179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.891 ' HB ' HD12 ' A' ' 175' ' ' LEU . 9.8 t -117.74 117.69 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 109.654 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.575 ' C ' HD12 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -128.93 140.92 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 110.341 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.59 ' O ' ' CG ' ' A' ' 193' ' ' PHE . 5.3 p90 -87.91 123.43 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.054 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.25 146.06 47.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.269 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -104.77 110.39 22.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.867 . . . . 0.0 110.137 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 -143.21 0.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.887 . . . . 0.0 110.139 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.901 ' O ' HD12 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -74.49 158.64 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 109.943 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.916 HG22 ' HG2' ' A' ' 118' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.128 -179.974 . . . . . . . . 2 2 . 1 stop_ save_